Tags: Cancer | melanoma | breakthrough | fda | regulators | merck | skin

Regulators Say New Melanoma Drug is ‘Breakthrough’

Wednesday, 24 Apr 2013 04:50 PM

 

U.S. regulators have granted Merck & Co.'s experimental treatment for advanced melanoma a "breakthrough therapy" designation, which could speed development and regulatory review of the product.
 
The medicine, whose chemical name is lambrolizumab, is also being tested against other forms of cancer. It belongs to a promising class of therapies that harness the body's immune system to find and attack cancer cells. It targets a protein called PD-1, or Programmed Death receptor.
 
The FDA created the "breakthrough therapy" designation earlier this year for medicines deemed likely to demonstrate "substantial improvement" over existing drugs.
 
Although it is intended to provide an easier path for drug development, Merck said it was not yet clear what specific benefits the designation would afford.

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

MRI Improves Prostate Cancer Biopsy Accuracy

Tuesday, 27 Jan 2015 16:34 PM

Prostate biopsies that combine MRI technology with ultrasound appear to give men better information regarding the seriou . . .

Prostate Cancer Patients Who Smoke Double Death Risk

Tuesday, 27 Jan 2015 12:20 PM

Smoking doubles the chances that a prostate cancer patient will see his disease spread and that he will eventually die f . . .

Epilepsy Drug Combats Breast Cancer

Tuesday, 27 Jan 2015 11:50 AM

A drug used to combat epilepsy has been found to reduce the growth and spread of breast cancer. . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved